- Home
- DNLI vs DKL Comparison
DNLI vs DKL Comparison
Compare DNLI & DKL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNLI
- DKL
- Stock Information
- Founded
- DNLI 2013
- DKL 2012
- Country
- DNLI United States
- DKL United States
- Employees
- DNLI N/A
- DKL N/A
- Industry
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- DKL Natural Gas Distribution
- Sector
- DNLI Health Care
- DKL Energy
- Exchange
- DNLI Nasdaq
- DKL Nasdaq
- Market Cap
- DNLI 2.1B
- DKL 2.3B
- IPO Year
- DNLI 2017
- DKL N/A
- Fundamental
- Price
- DNLI $14.21
- DKL $42.80
- Analyst Decision
- DNLI Strong Buy
- DKL Buy
- Analyst Count
- DNLI 15
- DKL 4
- Target Price
- DNLI $33.85
- DKL $44.25
- AVG Volume (30 Days)
- DNLI 1.7M
- DKL 102.3K
- Earning Date
- DNLI 07-31-2025
- DKL 08-05-2025
- Dividend Yield
- DNLI N/A
- DKL 10.41%
- EPS Growth
- DNLI N/A
- DKL 7.97
- EPS
- DNLI N/A
- DKL 2.98
- Revenue
- DNLI N/A
- DKL $938,491,000.00
- Revenue This Year
- DNLI N/A
- DKL $21.19
- Revenue Next Year
- DNLI $335.74
- DKL N/A
- P/E Ratio
- DNLI N/A
- DKL $14.30
- Revenue Growth
- DNLI N/A
- DKL N/A
- 52 Week Low
- DNLI $10.57
- DKL $34.59
- 52 Week High
- DNLI $33.33
- DKL $45.71
- Technical
- Relative Strength Index (RSI)
- DNLI 49.63
- DKL 54.22
- Support Level
- DNLI $13.41
- DKL $42.05
- Resistance Level
- DNLI $14.66
- DKL $43.18
- Average True Range (ATR)
- DNLI 0.63
- DKL 0.85
- MACD
- DNLI -0.03
- DKL -0.14
- Stochastic Oscillator
- DNLI 40.82
- DKL 37.38
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.
About DKL Delek Logistics Partners L.P. Common Units representing Limited Partner Interests
Delek Logistics Partners LP owns and operates logistics and marketing assets for crude oil and intermediate and refined products. The company's segment includes gathering and processing; wholesale marketing and terminalling; storage and transportation and investment in pipeline joint ventures. It generates maximum revenue from the wholesale marketing and terminalling segment, which provides marketing services for the refined products output of the Delek Holdings' refineries, engages in wholesale activity at its terminals and terminals owned by third parties, whereby it purchases light product for sale and exchange to third parties, and provides terminalling services at its refined products terminals to independent third parties and Delek Holdings.